by Lisa Chamoff
, Contributing Reporter | July 22, 2014
From the July 2014 issue of HealthCare Business News magazine
Short track speed skater J.R. Celski did plenty of hard work to become one of the best comeback stories of the 2010 Winter Games, recovering after his thigh was sliced by the blade of his own skate just five months before the competition and going on to win two bronze medals in Vancouver.
Although it didn’t get much attention from the mainstream media, ultrasound played a big role in tracking Celski’s recovery and allowed him to start training for the games earlier than expected, says Dr. Bill Moreau, managing director of sports medicine for the U.S. Olympic Committee, who served as medical director for Team USA at the recent Sochi Games. In fact, the use of ultrasound imaging to diagnose musculoskeletal injuries and track treatment is increasingly becoming the gold standard for U.S. Olympic athletes, surpassing MRI, so it’s no surprise that the musculoskeletal market remains the fastest growing area for ultrasound.
Moreau explains that ultrasound is the best way to distinguish between tendonitis and tendinosis, looking for vascular changes in the tendon and leading to the correct diagnosis. It’s also especially useful for follow- up and assessing whether someone is healing — a noninvasive, low-cost test that is good for both professional athletes and regular folks.
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
“It takes a lot of the guesswork out of return to play decision making,” Moreau says. “Ultrasound has been around for a long time. Now we can see there’s a much greater focus on it, especially in musculoskeletal medicine.”
It’s been said for years now that ultrasound is in the midst of a revival, with continued efforts to limit radiation exposure and lower health care costs. A recent study by 15 U.S. medical centers showed that although use of CT scans has risen for diagnosing kidney stones, CT is no better than ultrasound, which is less expensive and reduces patients’ exposure to radiation.
In reality, the U.S. market is growing, but the rate has slowed a bit from the double-digit growth seen in 2011. Last year, overall U.S. sales were up nearly 3 percent, according to a report published in April by Klein Biomedical Consultants. There is still a lot of movement in the point of care sector, including the musculoskeletal area, which grew 26 percent in 2013, according to the report.
The Klein report predicts the U.S. ultrasound market will grow to $1.88 billion by 2018, representing an annual rate of growth of 5.8 percent, while the firm Transparency Market Research predicts that the global ultrasound market will grow steadily over the next several years, at an estimated compound annual growth rate of nearly 5 percent.